Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

Moderna seeks authorization for COVID-19 vaccine in children as young as 6 months old

By Brian Buntz | April 28, 2022

ModernaWhile a portion of the public is now eligible to receive a second booster dose of COVID-19 vaccine, the FDA has not yet authorized a vaccine for children aged 6 months to 5 years old.

Moderna (Nasdaq:MRNA) is vying to be the first. The company announced today that it is filing a request for emergency use authorization (EUA) for its mRNA-1273 vaccine in young children. The company anticipates that it will complete the filing next week.

The request breaks young children into two groups, with the first covering the ages of 6 months to under 2 years and the second covering kids between 2 and 5 years old. The authorization request refers to a primary series consisting of two 25-μg doses of mRNA-1273.

Moderna also seeks similar authorizations for young children from other international regulatory bodies.

The company is basing the requests on positive interim data from the Phase 2/3 KidCOVE study, which met its primary endpoint.

The study analyzed antibody titers and concluded that the immunogenicity and reactogenicity of the vaccine in young children appeared to be similar to that of adults in Moderna’s Phase 3 COVE study.

The data collected in the KidCOVE study largely coincided with the omicron wave.

Moderna is also testing booster doses of its vaccine in children.

Pfizer and BioNTech are also pursuing regulatory authorization for their COVID-19 vaccine in young children. However, the two companies agreed to gather more data earlier this year before seeking such authorization.

On April 25, a House committee submitted a letter to FDA Commissioner Dr. Robert Califf seeking clarification concerning FDA’s plans to authorize COVID-19 vaccines in young children.

The Biden administration had reportedly discussed delaying authorization of COVID-19 vaccines in young children until June, according to a Politico article.

Chief Medical Advisor to the President Dr. Anthony Fauci recently said that FDA was mulling authorizing the Moderna and Pfizer vaccines in young children simultaneously to simplify messaging to parents. The Pfizer vaccine will like consist of a three-dose primary series for young children in contrast to Moderna’s, which would likely require two.


Filed Under: clinical trials, Drug Discovery, Infectious Disease
Tagged With: COVID-19 vaccination, COVID-19 vaccine, Moderna, Moderna COVID-19 vaccine
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Pfizer-BioNTech
FDA allows booster dose Pfizer-BioNTech COVID-19 vaccine in children 5 to 11
AstraZeneca RQ Biotechnology
AstraZeneca paying up to $157M for broad-spectrum monoclonal antibodies against COVID
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative
Olumiant
FDA approves Olumiant for treating some hospitalized COVID-19 patients

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50